Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C6H14FO3P |
| Molecular Weight | 184.1457 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
CC(C)OP(F)(=O)OC(C)C
InChI
InChIKey=MUCZHBLJLSDCSD-UHFFFAOYSA-N
InChI=1S/C6H14FO3P/c1-5(2)9-11(7,8)10-6(3)4/h5-6H,1-4H3
| Molecular Formula | C6H14FO3P |
| Molecular Weight | 184.1457 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
DescriptionSources: https://www.drugs.com/mmx/isoflurophate.html
Sources: https://www.drugs.com/mmx/isoflurophate.html
Isofluorophate (diisopropyl fluorophosphate) is an irreversile acetylcholinesterase inhibitor. It was used in ophthalmology as a miotic agent in treatment of chronic glaucoma.
Originator
Sources: http://www.fluoride-history.de/p-mfp.htm
Curator's Comment: On Dec. 11th, 1941, Bernard Charles Saunders, University of Cambridge, UK, reported at a Ministry of Supply meeting in London the highly toxic nature of an ester of monofluorophosphoric acid, diisopropyl fluorophosphate (DFP), as a lethal inhalant.
Approval Year
Targets
| Primary Target | Pharmacology | Condition | Potency |
|---|---|---|---|
Target ID: CHEMBL220 Sources: https://www.ncbi.nlm.nih.gov/pubmed/20189400 |
6.0 µM [Ki] |
Conditions
| Condition | Modality | Targets | Highest Phase | Product |
|---|---|---|---|---|
| Primary | FLOROPRYL Approved UseIsoflurophate is used as ocular drops in the treatment of chronic glaucoma. Isoflurophate is an organophosphorus compound that acts as an irreversible cholinesterase inhibitor. As such, it displays parasympathomimetic effects. Isoflurophate is used in the eye to treat certain types of glaucoma and other eye conditions, such as accommodative esotropia. They may also be used in the diagnosis of certain eye conditions, such as accommodative esotropia. Isoflurophate damages the acetylcholinesterase enzyme and is therefore irreversible, however, pralidoxime can displace organophosphates such as isoflurophate from acetylcholinesterase, but only if administered before isoflurophate damages (alkylates) the enzyme. Launch Date1957 |
PubMed
| Title | Date | PubMed |
|---|---|---|
| Lesions of rat skeletal muscle after local block of acetylcholinesterase and neuromuscular stimulation. | 2003-06 |
|
| Purification and characterization of PrbA, a new esterase from Enterobacter cloacae hydrolyzing the esters of 4-hydroxybenzoic acid (parabens). | 2003-04-11 |
|
| The cholinesterase inhibitor DFP facilitates the expression of paradoxical sleep (PS) propensity in rats subjected to short-term PS deprivation. | 2003-03-07 |
|
| Structural and enzymatic characterization of physarolisin (formerly physaropepsin) proves that it is a unique serine-carboxyl proteinase. | 2003-02-21 |
|
| Influence of gender on thermoregulation and cholinesterase inhibition in the long-evans rat exposed to diazinon. | 2003-02-14 |
|
| AMPA receptor potentiation by acetylcholinesterase is age-dependently upregulated at synaptogenesis sites of the rat brain. | 2003-02 |
|
| Protease-activated receptor mediated RhoA signaling and cytoskeletal reorganization in LNCaP cells. | 2003-01-28 |
|
| Chlorophyllase as a serine hydrolase: identification of a putative catalytic triad. | 2003-01 |
|
| A butyrylcholinesterase in the early development of the brine shrimp (Artemia salina) larvae: a target for phthalate ester embryotoxicity? | 2002-12-13 |
|
| Rapid assessment of organophosphorous/carbamate exposure in the bivalve mollusc Mytilus edulis using combined esterase activities as biomarkers. | 2002-12-03 |
|
| Involvement of nitric oxide in myotoxicity produced by diisopropylphosphorofluoridate (DFP)-induced muscle hyperactivity. | 2002-12 |
|
| Deacylation of N-arylformamides and N-arylacetamides by formamidase in rat liver. | 2002-12 |
|
| The crystal structure of the Epstein-Barr virus protease shows rearrangement of the processed C terminus. | 2002-11-15 |
|
| A mechanism-based probe for gp120-Hydrolyzing antibodies. | 2002-11-04 |
|
| Production of interleukin-1 activity of Kupffer cells from mice treated with the acidic mannan fraction of baker's yeast. | 2002-11 |
|
| Characterization of the receptor-destroying enzyme activity from infectious salmon anaemia virus. | 2002-11 |
|
| Atomic resolution crystal structure of squid ganglion DFPase. | 2002-10 |
|
| High-activity enzyme-polyurethane coatings. | 2002-09-30 |
|
| Gulf War related exposure factors influencing topical absorption of 14C-permethrin. | 2002-09-05 |
|
| Behavioral characteristics of rat lines selected for differential hypothermic responses to cholinergic or serotonergic agonists. | 2002-09 |
|
| Identification of two cysteine residues involved in the binding of UDP-GalNAc to UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferase 1 (GalNAc-T1). | 2002-09 |
|
| Analysis of organophosphorus compound adducts of serine proteases by liquid chromatography-tandem mass spectrometry. | 2002-08-25 |
|
| Functional dissociation between proforms and mature forms of proteinase 3, azurocidin, and granzyme B in regulation of granulopoiesis. | 2002-07 |
|
| Characterization and molecular cloning of a glutamyl endopeptidase from Staphylococcus epidermidis. | 2002-07 |
|
| Radiosynthesis and mouse brain distribution studies of [11C] CP-126,998: a PET ligand for in vivo study of acetylcholinesterase. | 2002-07 |
|
| Pyridostigmine bromide modulates the dermal disposition of [14C]permethrin. | 2002-06-15 |
|
| Covalent reactivity of phosphonate monophenyl esters with serine proteinases: an overlooked feature of presumed transition state analogs. | 2002-06-15 |
|
| Nanocrystalline metal oxides as destructive adsorbents for organophosphorus compounds at ambient temperatures. | 2002-06-03 |
|
| Purification and characterization of an esterase from Acinetobacter lwoffii I6C-1. | 2002-06 |
|
| Rat mast cell protease 4 is a beta-chymase with unusually stringent substrate recognition profile. | 2002-05-24 |
|
| Identification and characterization of prolylcarboxypeptidase as an endothelial cell prekallikrein activator. | 2002-05-17 |
|
| Degradation of glyceraldehyde-3-phosphate dehydrogenase induced by acetylleucine chloromethyl ketone in U937 cells. | 2002-05-15 |
|
| Kinetic analysis of a unique direct prothrombinase, fgl2, and identification of a serine residue critical for the prothrombinase activity. | 2002-05-15 |
|
| [Amylases of the fungus Aspergillus flavipes associated with Fucus evanescens]. | 2002-04-19 |
|
| Presence of a mobilizable intracellular pool of hepatocyte growth factor in human polymorphonuclear neutrophils. | 2002-04-15 |
|
| A novel N(alpha)-acetyl alanine aminopeptidase from Allomyces arbuscula. | 2002-04 |
|
| Purification and characterization of a collagenolytic protease from the filefish, Novoden modestrus. | 2002-03-31 |
|
| Sulfur mustard-stimulated protease: a target for antivesicant drugs. | 2002-03-29 |
|
| Dipeptidyl peptidase with strict substrate specificity of an anaerobic periodontopathogen Porphyromonas gingivalis. | 2002-03-19 |
|
| Early differential elevation and persistence of phosphorylated cAMP-response element binding protein (p-CREB) in the central nervous system of hens treated with diisopropyl phosphorofluoridate, an OPIDN-causing compound. | 2002-03 |
|
| Functional proteomics using microchannel plate detectors. | 2002-03 |
|
| EstB from Burkholderia gladioli: a novel esterase with a beta-lactamase fold reveals steric factors to discriminate between esterolytic and beta-lactam cleaving activity. | 2002-03 |
|
| Characterization of the residues involved in the human alpha-thrombin-haemadin complex: an exosite II-binding inhibitor. | 2002-02-26 |
|
| An antibody that binds to primary specific pocket-associated structure in the active site of bovine thrombin. | 2002-02 |
|
| Ionomycin-induced neutrophil NADPH oxidase activity is selectively inhibited by the serine protease inhibitor diisopropyl fluorophosphate. | 2002-02 |
|
| Purification and some properties of a keratinolytic enzyme from an alkaliphilic Nocardiopsis sp. TOA-1. | 2002-01 |
|
| Effect of meconium on the rate of in vitro subtype conversion of swine pulmonary surfactant. | 2002-01 |
|
| Carboxylesterase: specificity and spontaneous reactivation of an endogenous scavenger for organophosphorus compounds. | 2001-12 |
|
| Organophosphorus compounds alter intracellular F-actin content in SH-SY5Y human neuroblastoma cells. | 2001-12 |
|
| Eptastigmine: ten years of pharmacology, toxicology, pharmacokinetic, and clinical studies. | 2001 |
Sample Use Guides
In Vivo Use Guide
Sources: https://www.drugs.com/mmx/isoflurophate.html
Topical, to the conjunctiva, a thin strip (approximately 0.5 cm) of a 0.025% ointment once every three days to three times a day.
Route of Administration:
Topical
In Vitro Use Guide
Sources: https://www.ncbi.nlm.nih.gov/pubmed/20189400
Recombinant AChE was quantitated using the extinction coefficient 119, 650 M-1 cm-1 calculated from its amino acid sequence. AChE (34 nM) was assayed using Ellman’s reagent using 160 uM acetylthiocholine and 300 uM 5,50-dithiobis-2-ntirobenzoic acid (DTNB). Thiocholine released by the enzyme reacts with excess DTNB, resulting in the formation of the thionitrobenzoate anion, which absorbs at 412 nm. To assess IC50, the inhibitors were solubilized in isopropanol and used in volumes of less than 5% of the total reaction volume. AChE (34 nM) was incubated for 30 min with each compound at an array of concentrations. The residual activity of the enzyme was assayed using 500 uM acetylthiocholine, a saturating concentration 10-fold higher than the Km of 46 uM for this substrate.
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:33:24 GMT 2025
by
admin
on
Mon Mar 31 18:33:24 GMT 2025
|
| Record UNII |
12UHW9R67N
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Code | English | ||
|
Brand Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Classification Tree | Code System | Code | ||
|---|---|---|---|---|
|
NCI_THESAURUS |
C47792
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
||
|
EPA PESTICIDE CODE |
356100
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
||
|
WHO-ATC |
S01EB07
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
DTXSID1040667
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
55-91-4
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
CHEMBL1025
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
DIISOPROPYL FLUOROPHOSPHATE
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
1494
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
12UHW9R67N
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
6027
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | RxNorm | ||
|
17941
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
DB00677
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
200-247-6
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
m6492
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | Merck Index | ||
|
D007531
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
100000077389
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
SUB14274MIG
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
2133
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
5936
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
727370
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY | |||
|
C65979
Created by
admin on Mon Mar 31 18:33:24 GMT 2025 , Edited by admin on Mon Mar 31 18:33:24 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |